Bernard A. Fox, Co-founder, President, and CEO of UbiVac, shared a post on LinkedIn:
“Cancer Vaccines & Combination Immunotherapy!!!
October has been filled with exciting data on cancer vaccines! From melanoma, Pancreatic Cancer, Breast Cancer, Lung Cancer, Head and Neck Cancer, Bladder Cancer, Canine, Sarcoma and Lynch Syndrome.
It started with VAXON 2025! It was an honor and great pleasure to organize this program with Paolo A. Ascierto, who was appointed Full Professor of Oncology on the day of the meeting! Congrats again Paolo for this well deserved promotion.
Already looking forward to VAXON 2026!
Thanks to the faculty and colleagues for participating in this conference, that was wonderfully organized by Vivenko.
Appreciate comments and discussions with others including Alan Korman, Giorgio Massimini, Henry Yu and others.”
More posts featuring Bernard A Fox on OncoDaily.
